4480av为您找到"

NOACs

"相关结果

Dabigatran versus Warfarin in Patients with Mechanical ...https://www.nejm.org/doi/full/10.1056/NEJMoa1300615Dabigatran is an oral direct thrombin inhibitor that has been shown to be an effective alternative to warfarin in patients with atrial fibrillation. We evaluated the use of dabigatran in patients with mechanical heart valves. In this phase 2 dose-validation study, we studied two populations of ...

Dabigatran is an oral direct thrombin inhibitor that has been shown to be an effective alternative to warfarin in patients with atrial fibrillation. We evaluated the use of dabigatran in patients with mechanical heart valves. In this phase 2 dose-validation study, we studied two populations of ...
www.nejm.org/doi/full/10.1056/NEJMoa1300615

新規経口抗凝固薬(Newly Oral Anticoagulants, …

総説 新規経口抗凝固薬(Newly Oral Anticoagulants, NOACs)服用中に 生じた出血合併症—「NOACs 神話」は本当か?— 山﨑雅英
www.keiju.co.jp/manage/files/iryo/magazine_2015_02...

ログインhttps://icekyoto.org/NOACs3/Account/Login.aspx · Translate this page動作環境 1.ご利用になるブラウザーは、Internet Explorer8.0以上のバージョンでご利用ください。 2.ブラウザの設定で、cookie及びJavaScriptが有効な状態でご利用ください。

動作環境 1.ご利用になるブラウザーは、Internet Explorer8.0以上のバージョンでご利用ください。 2.ブラウザの設定で、cookie及びJavaScriptが有効な状態でご利用ください。
icekyoto.org/NOACs3/Account/Login.aspx

Know Your NOACs - Medscapehttps://www.medscape.com/viewarticle/831524_2Although NOACs have many attractive features, such as minimal interaction with medications and foods and no need for bloodwork monitoring, they also have several important limitations. None of the NOAC medications are FDA-approved for patients with valvular disease. A randomized trial of dabigatran ...

Although NOACs have many attractive features, such as minimal interaction with medications and foods and no need for bloodwork monitoring, they also have several important limitations. None of the NOAC medications are FDA-approved for patients with valvular disease. A randomized trial of dabigatran ...
www.medscape.com/viewarticle/831524_2

IV tPA in Patients Taking NOACs Before Ischemic …https://www.acc.org/latest-in-cardiology/journal-scans/2017/02/03/...The authors used data from the Get With the Guidelines (GWTG)-Stroke Registry, a nationwide voluntary registry that tracks patient-level data at participating hospitals. Patients treated with IV tPA were divided into three groups: those taking NOACs, those taking warfarin (with an international ...

The authors used data from the Get With the Guidelines (GWTG)-Stroke Registry, a nationwide voluntary registry that tracks patient-level data at participating hospitals. Patients treated with IV tPA were divided into three groups: those taking NOACs, those taking warfarin (with an international ...
www.acc.org/latest-in-cardiology/journal-scans/201...

Nature of Action Codes for Reporting Awards to CPDFwww.opm.gov/.../nature-of-action-codes-for-reporting-awards-to-cpdfNature of Action Codes for Reporting Awards to CPDF. The Office of Personnel Management is changing the nature of action codes used to report awards data to the Central Personnel Data File.

Nature of Action Codes for Reporting Awards to CPDF. The Office of Personnel Management is changing the nature of action codes used to report awards data to the Central Personnel Data File.
www.opm.gov/.../nature-of-action-codes-for-reporti...

Three new alternatives to warfarin for atrial fibrillation ...www.drholdright.co.uk/dynamicpage.php?pg=news&hd=News&pageid=MTE1All three NOACs reduce the risk of stroke due to bleeding (haemorrhagic stroke) compared with warfarin. Dabigatran and apixaban cause less major and minor bleeding ,whereas rivaroxaban predisposes to more major bleeds from the gut, as does the higher dose of dabigatran, all compared with warfarin.

All three NOACs reduce the risk of stroke due to bleeding (haemorrhagic stroke) compared with warfarin. Dabigatran and apixaban cause less major and minor bleeding ,whereas rivaroxaban predisposes to more major bleeds from the gut, as does the higher dose of dabigatran, all compared with warfarin.
www.drholdright.co.uk/dynamicpage.php?pg=news&...

NOACs and Your Dental Treatment - SDCEP

Scottish Dental Clinical Effectiveness Programme SDcep This information is for anyone who is taking one of the NOACs (Novel Oral Anticoagulants): • dabigatran (Pradaxa); • rivaroxaban (Xarelto); • apixaban (Eliquis), and needs dental treatment.
www.sdcep.org.uk/wp-content/uploads/2015/09/NOACs-...

Novel anticoagulants - Drug cabinet - Heart Matters …https://www.bhf.org.uk/.../medical/drug-cabinet/novel-anticoagulantsNovel anticoagulants For over 50 years, warfarin has been the drug of choice in preventing AF-related strokes, but a new type of anticoagulant offers more options.

Novel anticoagulants For over 50 years, warfarin has been the drug of choice in preventing AF-related strokes, but a new type of anticoagulant offers more options.
www.bhf.org.uk/.../medical/drug-cabinet/novel-anti...